Explore Multiple Myeloma Conditions and Indications. Learn to recognize the CRAB criteria, persistent bone pain, and early warning signs that require immediate care.
Send us all your questions or requests, and our expert team will assist you.
Multiple Myeloma Conditions and Indications
Identifying the signs of multiple myeloma can be challenging because the early symptoms are often vague and easily mistaken for less serious conditions, such as aging or general fatigue. However, recognizing these indications early is the most critical step toward effective treatment and successful stem cell transplantation.
At Liv Hospital, we believe that an informed patient is an empowered patient. Understanding the specific signals your body is sending from persistent bone pain to unexplained exhaustion can lead to a faster diagnosis and a more personalized treatment plan. This guide details the clinical conditions associated with multiple myeloma, explaining the “CRAB” criteria used by doctors worldwide and helping you distinguish between routine aches and signs that require immediate medical attention.
In the earliest stages, multiple myeloma may not cause any symptoms at all. This is often referred to as “smoldering” or “asymptomatic” myeloma. However, as the plasma cells continue to multiply in the bone marrow, they begin to crowd out healthy blood cells and produce abnormal proteins that affect various organs.
The most common early complaints usually involve:
If you are experiencing these symptoms for more than a few weeks without a clear cause, it is essential to undergo a clinical evaluation.
Doctors use a specific set of clinical indicators, known by the acronym CRAB, to determine if multiple myeloma is active and requires immediate treatment. The presence of one or more of these conditions is often the deciding factor in moving from “observation” to “intervention.”
When myeloma cells damage the bones, calcium is released into the bloodstream. High levels of calcium (hypercalcemia) can be dangerous and cause distinct symptoms:
The abnormal antibody proteins (M proteins) produced by myeloma cells can clog the kidneys’ filtering system, leading to a condition often called “myeloma kidney.”
As myeloma cells take over the bone marrow, there is less room for the production of red blood cells.
This is the most common indication, affecting nearly 85% of patients. Myeloma cells produce chemicals that speed up the breakdown of old bone and slow down the formation of new bone.
Beyond the CRAB criteria, multiple myeloma can manifest in other ways that affect a patient’s quality of life and treatment eligibility.
In some cases, the level of M protein in the blood becomes so high that it thickens the blood (like syrup), making it difficult to circulate through small blood vessels.
Rarely, the antibody proteins produced by myeloma cells can link together to form a sticky substance called amyloid. This substance can deposit in organs like the heart, kidneys, and nerves, causing them to stiffen and malfunction.
Because the cancerous plasma cells do not make functional antibodies, the body loses its primary defense against viruses and bacteria. Patients often find themselves battling the same infection repeatedly or taking longer than normal to recover from a cold.
At Liv Hospital, we specialize in distinguishing between complex blood disorders. We understand that waiting for answers is the hardest part. Our international patient program is designed to expedite the evaluation process.
Upon arrival, patients with suspected myeloma undergo a comprehensive review of their symptoms. We focus not just on the cancer, but on stabilizing the complications treating the kidney function, managing bone pain, and correcting calcium levels before moving to long-term therapies like autologous stem cell transplantation.
Muscle pain and fatigue are common in everyday life, so how do you know when it’s serious? You should consult a specialist if you experience:
Not all multiple myeloma cases behave the same way. Part of evaluating your condition involves determining if you have “Standard Risk” or “High Risk” myeloma. This is based on specific genetic markers found in the plasma cells.
Determining your risk level is crucial because it dictates the urgency and type of treatment you will receive.
Send us all your questions or requests, and our expert team will assist you.
No. Back pain is extremely common and usually caused by muscle strain or disc issues. However, back pain associated with multiple myeloma is typically persistent, does not improve with standard rest, and may be accompanied by other symptoms like fatigue or weight loss. If you have deep, gnawing bone pain at night, it should be evaluated.
Smoldering myeloma is asymptomatic, meaning you likely won’t feel anything different. It is usually discovered accidentally during blood tests for other conditions. Even though you feel fine, regular monitoring is essential to catch the transition to active myeloma early.
Yes. Hypercalcemia can be caused by hyperparathyroidism, dehydration, or certain medications. However, if high calcium is found alongside anemia or kidney issues, multiple myeloma is a strong suspect.
Generally, no. Multiple myeloma stays within the bone marrow. However, in advanced cases, plasma cells can form tumors outside the bone (extramedullary plasmacytomas), which might be felt as soft lumps under the skin, though this is rare.
The core symptoms (CRAB criteria) remain the same regardless of age. However, younger patients may tolerate anemia and kidney stress better than older patients, potentially masking the severity of the disease for longer. This makes proactive testing even more important.
Your Comparison List (you must select at least 2 packages)
